                         SEQUENCE LISTING

<110>  YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO. LTD.
 
<120>  ANTIBODIES BINDING TO CANINE VASCULAR ENDOTHELIAL GROWTH FACTOR 
       AND USES THEREOF IN TREATING CANINE DISEASES

<130>  Y0112.70000WO00

<140>  Not yet assigned
<141>  Concurrently herewith

<150>  US 14/679,573
<151>  2015-04-06

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  1389
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  1
atggaatgga cctgggtctt tctcttcctc ctgtcagtaa ctgcaggtgt ccactcccag       60

gttcagctgc agcagtctgg agctgagctg atgaagcctg gggcctcagt gaaaatatcc      120

tgcaaggcta ctggctacac attcagtagc tactggatag agtgggtaaa gcagaggcct      180

ggacatggcc ttgagtggat tggagagatt tttcctggag gtggtgatcc taaatacaat      240

gagaatttca agggcaaggc cacattcact acagatgcat cctccaacac agcctacatg      300

caactcagca gcctgacatc tgaggactct gccgtctatt actgtgcaag aggaaccttc      360

gggttctatg ctatggacta ctggggtcaa ggaacctcag tcaccgtctc ctcagccaaa      420

acgacacccc catctgtcta tccactggcc cctggatctg ctgcccaaac taactccatg      480

gtgaccctgg gatgcctggt caagggctat ttccctgagc cagtgacagt gacctggaac      540

tctggatccc tgtccagcgg tgtgcacacc ttcccagctg tcctgcagtc tgacctctac      600

actctgagca gctcagtgac tgtcccctcc agcacctggc ccagcgagac cgtcacctgc      660

aacgttgccc acccggccag cagcaccaag gtggacaaga aaattgtgcc cagggattgt      720

ggttgtaagc cttgcatatg tacagtccca gaagtatcat ctgtcttcat cttcccccca      780

aagcccaagg atgtgctcac cattactctg actcctaagg tcacgtgtgt tgtggtagac      840

atcagcaagg atgatcccga ggtccagttc agctggtttg tagatgatgt ggaggtgcac      900

acagctcaga cgcaaccccg ggaggagcag ttcaacagca ctttccgctc agtcagtgaa      960

cttcccatca tgcaccagga ctggctcaat ggcaaggagt tcaaatgcag ggtcaacagt     1020

gcagctttcc ctgcccccat cgagaaaacc atctccaaaa ccaaaggcag accgaaggct     1080

ccacaggtgt acaccattcc acctcccaag gagcagatgg ccaaggataa agtcagtctg     1140

acctgcatga taacagactt cttccctgaa gacattactg tggagtggca gtggaatggg     1200

cagccagcgg agaactacaa gaacactcag cccatcatgg acacagatgg ctcttacttc     1260

gtctacagca agctcaatgt gcagaagagc aactgggagg caggaaatac tttcacctgc     1320

tctgtgttac atgagggcct gcacaaccac catactgaga agagcctctc ccactctcct     1380

ggtaaatga                                                             1389


<210>  2
<211>  462
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Met Glu Trp Thr Trp Val Phe Leu Phe Leu Leu Ser Val Thr Ala Gly 
1               5                   10                  15      


Val His Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Met Lys 
            20                  25                  30          


Pro Gly Ala Ser Val Lys Ile Ser Cys Lys Ala Thr Gly Tyr Thr Phe 
        35                  40                  45              


Ser Ser Tyr Trp Ile Glu Trp Val Lys Gln Arg Pro Gly His Gly Leu 
    50                  55                  60                  


Glu Trp Ile Gly Glu Ile Phe Pro Gly Gly Gly Asp Pro Lys Tyr Asn 
65                  70                  75                  80  


Glu Asn Phe Lys Gly Lys Ala Thr Phe Thr Thr Asp Ala Ser Ser Asn 
                85                  90                  95      


Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val 
            100                 105                 110         


Tyr Tyr Cys Ala Arg Gly Thr Phe Gly Phe Tyr Ala Met Asp Tyr Trp 
        115                 120                 125             


Gly Gln Gly Thr Ser Val Thr Val Ser Ser Ala Lys Thr Thr Pro Pro 
    130                 135                 140                 


Ser Val Tyr Pro Leu Ala Pro Gly Ser Ala Ala Gln Thr Asn Ser Met 
145                 150                 155                 160 


Val Thr Leu Gly Cys Leu Val Lys Gly Tyr Phe Pro Glu Pro Val Thr 
                165                 170                 175     


Val Thr Trp Asn Ser Gly Ser Leu Ser Ser Gly Val His Thr Phe Pro 
            180                 185                 190         


Ala Val Leu Gln Ser Asp Leu Tyr Thr Leu Ser Ser Ser Val Thr Val 
        195                 200                 205             


Pro Ser Ser Thr Trp Pro Ser Glu Thr Val Thr Cys Asn Val Ala His 
    210                 215                 220                 


Pro Ala Ser Ser Thr Lys Val Asp Lys Lys Ile Val Pro Arg Asp Cys 
225                 230                 235                 240 


Gly Cys Lys Pro Cys Ile Cys Thr Val Pro Glu Val Ser Ser Val Phe 
                245                 250                 255     


Ile Phe Pro Pro Lys Pro Lys Asp Val Leu Thr Ile Thr Leu Thr Pro 
            260                 265                 270         


Lys Val Thr Cys Val Val Val Asp Ile Ser Lys Asp Asp Pro Glu Val 
        275                 280                 285             


Gln Phe Ser Trp Phe Val Asp Asp Val Glu Val His Thr Ala Gln Thr 
    290                 295                 300                 


Gln Pro Arg Glu Glu Gln Phe Asn Ser Thr Phe Arg Ser Val Ser Glu 
305                 310                 315                 320 


Leu Pro Ile Met His Gln Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys 
                325                 330                 335     


Arg Val Asn Ser Ala Ala Phe Pro Ala Pro Ile Glu Lys Thr Ile Ser 
            340                 345                 350         


Lys Thr Lys Gly Arg Pro Lys Ala Pro Gln Val Tyr Thr Ile Pro Pro 
        355                 360                 365             


Pro Lys Glu Gln Met Ala Lys Asp Lys Val Ser Leu Thr Cys Met Ile 
    370                 375                 380                 


Thr Asp Phe Phe Pro Glu Asp Ile Thr Val Glu Trp Gln Trp Asn Gly 
385                 390                 395                 400 


Gln Pro Ala Glu Asn Tyr Lys Asn Thr Gln Pro Ile Met Asp Thr Asp 
                405                 410                 415     


Gly Ser Tyr Phe Val Tyr Ser Lys Leu Asn Val Gln Lys Ser Asn Trp 
            420                 425                 430         


Glu Ala Gly Asn Thr Phe Thr Cys Ser Val Leu His Glu Gly Leu His 
        435                 440                 445             


Asn His His Thr Glu Lys Ser Leu Ser His Ser Pro Gly Lys 
    450                 455                 460         


<210>  3
<211>  717
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Polynucleotide

<400>  3
atgaagttgc ctgttaggct gttggtgctg atgttctgga ttcctgcttc cagcagtgat       60

gctgtgatga cccaaactcc actctccctg cctgtcagtc ttggagatca agtctccatc      120

tcttgcaggt ctagtcagag ccttgaaaac agtaatggaa acacctattt gaactggtac      180

ctccagaaac caggccagtc tccacagctc ctgatctaca gggtttccaa ccgattttct      240

ggggtcctag acaggttcag tggtagtgga tcagggacag atttcacact gaaaatcagc      300

agagtggagg ctgaggattt gggagtttat ttctgcctcc aagttacaca tgtcccctac      360

acgttcggag gggggaccaa gctggaaata aaacgggctg atgctgcacc aactgtatcc      420

atcttcccac catccagtga gcagttaaca tctggaggtg cctcagtcgt gtgcttcttg      480

aacaacttct accccaaaga catcaatgtc aagtggaaga ttgatggcag tgaacgacaa      540

aatggcgtcc tgaacagttg gactgatcag gacagcaaag acagcaccta cagcatgagc      600

agcaccctca cgttgaccaa ggacgagtat gaacgacata acagctatac ctgtgaggcc      660

actcacaaga catcaacttc acccattgtc aagagcttca acaggaatga gtgttag         717


<210>  4
<211>  238
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Met Lys Leu Pro Val Arg Leu Leu Val Leu Met Phe Trp Ile Pro Ala 
1               5                   10                  15      


Ser Ser Ser Asp Ala Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val 
            20                  25                  30          


Ser Leu Gly Asp Gln Val Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu 
        35                  40                  45              


Glu Asn Ser Asn Gly Asn Thr Tyr Leu Asn Trp Tyr Leu Gln Lys Pro 
    50                  55                  60                  


Gly Gln Ser Pro Gln Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser 
65                  70                  75                  80  


Gly Val Leu Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
                85                  90                  95      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys 
            100                 105                 110         


Leu Gln Val Thr His Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu 
        115                 120                 125             


Glu Ile Lys Arg Ala Asp Ala Ala Pro Thr Val Ser Ile Phe Pro Pro 
    130                 135                 140                 


Ser Ser Glu Gln Leu Thr Ser Gly Gly Ala Ser Val Val Cys Phe Leu 
145                 150                 155                 160 


Asn Asn Phe Tyr Pro Lys Asp Ile Asn Val Lys Trp Lys Ile Asp Gly 
                165                 170                 175     


Ser Glu Arg Gln Asn Gly Val Leu Asn Ser Trp Thr Asp Gln Asp Ser 
            180                 185                 190         


Lys Asp Ser Thr Tyr Ser Met Ser Ser Thr Leu Thr Leu Thr Lys Asp 
        195                 200                 205             


Glu Tyr Glu Arg His Asn Ser Tyr Thr Cys Glu Ala Thr His Lys Thr 
    210                 215                 220                 


Ser Thr Ser Pro Ile Val Lys Ser Phe Asn Arg Asn Glu Cys 
225                 230                 235             


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Gly Tyr Thr Phe Ser Ser Tyr Trp Ile Glu 
1               5                   10  


<210>  6
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  6

Glu Ile Phe Pro Gly Gly Gly Asp Pro Lys Tyr Asn Glu Asn Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Gly Thr Phe Gly Phe Tyr Ala Met Asp Tyr 
1               5                   10  


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  8

Arg Ser Ser Gln Ser Leu Glu Asn Ser Asn Gly Asn Thr Tyr Leu Asn 
1               5                   10                  15      


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  9

Arg Val Ser Asn Arg Phe Ser 
1               5           


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  10

Leu Gln Val Thr His Val Pro Tyr  
1               5                   


